FMP

FMP

Enter

MDGL - Madrigal Pharma...

photo-url-https://images.financialmodelingprep.com/symbol/MDGL.png

Madrigal Pharmaceuticals, Inc.

MDGL

NASDAQ

Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III clinical trials for the treatment of non-alcoholic steatohepatitis. The company also develops MGL-3745, a backup compound to resmetirom. It has research, development, and commercialization agreement with Hoffmann-La Roche. Madrigal Pharmaceuticals, Inc. is headquartered in West Conshohocken, Pennsylvania.

314.04 USD

2.04 (0.65%)

Historical Prices

From:

To:

We are unable to load the chart at this time.

fmp-logo

About

ceo

Mr. William J. Sibold

sector

Healthcare

industry

Biotechnology

exchange

NASDAQ

Description

Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III clinical trials for the treatment of non-alcoholic steatohepatitis. The company also develops MGL-3745, a backup compound to resmetirom. It has research, development, and commercialization agreement with Hoffmann-La Roche. Madrigal Pharmaceuticals, Inc. is headquartered in West Conshohocken, Pennsylvania.

CIK

0001157601

ISIN

US5588681057

CUSIP

558868105

Address

Four Tower Bridge

Phone

267 824 2827

Country

US

Employee

376

IPO Date

Feb 6, 2007

Financial Statement

We are unable to load the chart at this time.

fmp-logo

Earnings

We are unable to load the chart at this time.

fmp-logo

MDGL Financial Summary

CIK

0001157601

Exchange

NASDAQ

Industry

Biotechnology

Sector

Healthcare

CUSIP

558868105

ISIN

US5588681057

Country

US

Price

314.04

Beta

-0.47

Volume Avg.

428.16k

Market Cap

6.85B

Shares

-

52-Week

168.25-368.29

DCF

-0.92

ROE

-

ROA

-

Operating Margin

-

Debt/Equity

-

P/E

-12.55

P/B

-

Website

https://www.madrigalpharma.com

Upgrades and Downgrades

We are unable to load this data!

fmp-logo

Latest MDGL News

It looks like there's no news available.

fmp-logo
FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep